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Summary
We have developed a model of peripheral in vivo T cell tolerance that is induced by administration
of the protein superantigen staphylococcal enterotoxin B (SEB) . Rather than activating V08+
T cells, in vivo administration of SEB induced in them a profound state of anergy. This was
shown by their failure to proliferate to subsequent in vitro restimulation with SEB or to antiV08
antibodies. This unresponsiveness was V08 specific since T cells from SEB-immunized mice
responded normally to other antigens. 8 d after SEB administration, there was no reduction
in the number of Va8+ T cells or in the intensity of V08 T cell receptor (TCR) expression .
Although a portion of theV08+ T cells from SEB-primed mice were able to express interleukin
2 receptors (IIr2Rs), they failed to proliferate in response to exogenous IL2, indicating they
were defective in their IL-2 responsiveness. 2-4wk afterSEB administration, there was a reduction
of -50% in the number of V08+ cells in immunized compared with control animals . There
was, however, no reduction in the level of TCR expression on the remaining V08+ cells . These
data demonstrate that proteins that activate T cells in vitro in a V/3-specific manner can induce
a state of anergy in peripheral T cells in vivo and may possibly further mediate clonal deletion
in a portion of the tolerized cells.
D uring the development of a functional immune reper-
toire, antigen-specific components of theimmune system
must learn to discriminate selffrom non-self. Recent studies
have shown that to establish self tolerance many potentially
self-reactive T lymphocytes are clonally deleted intrathymi-
cally (1-5) . This has been demonstrated in systems wherein
the expression ofparticularTCR Vii regions correlates with
specificity to self antigens such as I-E and minor lymphocyte
stimulatory (Mls)l antigens (1-3), as well as in TCR trans-
genic mouse models (4, 5) . Additionally, it was demonstrated
that tolerance in the developing immune system can be ac-
quired by functional inactivation (anergy) in the absence of
clonal deletion, notably to self antigens expressed only on
thymic epithelium (6) or only extrathymically (7-9) .
Mature peripheral T cells can also be rendered tolerant in
vitro (10, 11) and in vivo (10, 12, 13) . The studies on in vivo
tolerance induction demonstrated that it is possible to in-
duce tolerance in mature T cells to minor or class I histocom-
patibility antigens (9, 12), to Mls antigens (12, 13), and to
protein antigens that were coupled to chemically modified
APC (10) . Furthermore, tolerance can be induced in mature
I Abbreviations used in thispaper . Mls, minor lymphocyte stimulatory ; PPD,
purified protein derivative ; SE, staphylococcal enterotoxin .
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T cells by soluble protein antigens after both in vivo or in
vitro priming (14-19) . Tolerance induction in these situations
was critically dependent upon factors such as the route of
administration (either intravenously or oral), and the amount
and chemical state of the antigen (monomeric rather than
aggregated) . Because TCR usage in these responses was un-
determined, it was not possible to distinguish among anergy,
clonal deletion, or regulation by suppressor cells as the mech-
anism of tolerance .
The purpose of the current investigation was to examine
the mechanisms of the induction of tolerance in vivo in ma-
ture peripheral T cells. In the current study, we demonstrate
that T cells from BALB/c mice primed with the superan-
tigen staphylococcal enterotoxinB (SEB) displayed a dramat-
ically diminished response to this antigen upon subsequent
in vitro activation . Because SEB has beenshown to specifically
activate T cells that express V08+ TCRs (20), we were able
to directly assay the activity of V08+ T cells using V/38-
specific antibodies . In vivo administration ofSEB (either sub-
cutaneously in adjuvant or intravenously) induces a state of
profound unresponsiveness in V08+ T cells, yet these cells
are present in normal numbers, with no apparent downregu-
lation of the level ofTCR expression. The observed unrespon-
siveness is specific because SEB-immunized animals respond
Medicine " Volume 172 October 1990 1091-1100normally to in vitro stimulation with other antigens. Thus,
these data demonstrate that a soluble protein that activates
T cells in a V(3-specific manner can induce tolerance in pe-
ripheral T cells by the induction of clonal anergy.
Materials and Methods
Animals.
￿
BALB/c and B10.BR mice (4-8 wk old) were pur-
chased from either the National Cancer Institute Frederick An-
imal Research Facility (Frederick, MD) or TheJackson Laboratory
(Bar Harbor, ME) . All otherinbred strains ofmice were purchased
from The Jackson Laboratory.
Reagents.
￿
SEB was purchased from Sigma Chemical Co. (St .
Louis, MO) . SEA was purchased from Toxin Technologies (Mad-
ison, WI) .
Fluorescence Staining (FACS).
￿
Cells were suspended in HBSS
(without phenol red) containing 1% BSA and 0.1% sodium azide
(FACS buffer) . Cells (106/100 pd buffer) were incubated for 30 min
on ice with 10 141 of the appropriate FITC-conjugated antibody.
For two-color analysis, alter washing, cells were incubated with
biotinylatedmAb to CD4 or CD8, and then allophycocfanin-labeled
avidin (Caltag Laboratories, Inc., San Francisco, CA) . Control
staining of cells with irrelevant antibody was used to obtain back-
ground fluorescence values. Single-color analysis was done on a FAC-
SCAN (Becton Dickinson &Co ., Mountain View, CA) interfaced
to a PDP 11/24 computer. Reagents used for direct staining were
FITC- or biotin-conjugated anti- : a/Q (21), CD8 (22), CD4 (23),
V03 (24), V/36 (25), V08 (26), and IL2R (27) .
T Cell Proliferation Assays.
￿
Mice were immunized in the hind
footpad with SEB (50 or 100 Pg/hind foot pad) emulsified in CFA
H37Ra (Difco Laboratories Inc., Detroit, MI) or CFA alone . In
some experiments, animals were injected with SEB in PBS intrave-
nously through the tail vein . 8, 14, or 30 d later, T cells pooled
from either the spleens or lymph nodes of three to five mice/group
were isolated by passage over nylon wool . Cultures were performed
in flat-bottomed microtiter wells (antigen-induced proliferation
assays) or round-bottomed microtiter wells (mAb-induced prolifer-
ation assays) in a 1 :1 mixture ofEagle's Hanks Amino Acids medium
and RPMI 1640 supplemented with 10% FCS, 2-ME (5 x 10-5
M), Hepes buffer, glutamine, penicillin, and gentamycin . For
antigen-induced proliferation, 105 T cells/well were stimulated
with 5 x 105 irradiated (2,000 rad) Thy-1.2- (New England Nu-
clear, Boston, MA) syngeneic spleen cells as a source of APC in
the presence of various concentrations of SEB, SEA, or 20 /Ag/ml
purified protein derivative (PPD) . After 3 d, cultures were pulsed
with 1 /Ci of [ 3Hlthymidine (New England Nuclear) and har-
vested 12-18 h later. For the experiments that assessed the effect
of exogenous IIr2 addition, 100 U/ml of rIL2 (Cetus Corp.,
Emeryville, CA) was added per well at the initiation of the culture
period . Thereafter, cell cultures were treated as described above .
To assay V/3-specific proliferation, purified mAbs were diluted
to 10 Ag/ml with PBS, and 30 Al was added per microtiter well .
Plates were incubated at 37°C for 2-3 h and then washed three
times with PBS before use. Various numbers ofT cells were added
in 100 al medium (see above) and were cultured in a total of 150
1.1 . After 3 d, cultures were pulsed with 1 ACi of ['H]thymidine
and harvested 12-18 h later. For all the proliferation assays, the ex-
perimental values shown represent the arithmetic means of deter-
minations performed in triplicate wells . SE were invariably<20%
of the mean .
Analysis ofIL2R Expression .
￿
Nylon wool-purified lymph node
T cells (5 x 10 5/ml) from BALB/c mice immunized with either
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SEB in adjuvant orCFA alone were stimulated with irradiated (2,000
rad) Thy-1.2 - syngeneic spleen cells (106/ml) as a source ofAPC
in the presence of 10 jig/ml SEB for 48 h. The culture medium
was as described above for theT cell proliferation assays. After 48 h,
aliquots of each culture (SEB vs . CFA) were removed and assessed
for proliferation by the addition of 1 ACi of ['H)thymidine . Pulsed
cells were harvested 12-18 h later. The remainder of the cells were
collected, washed once, and purified by density centrifugation over
Ficoll-Hypaque (Pharmacia, LKB Biotechnology, Inc., Piscataway,
NJ) to remove dead cells. The cells were then stained and analyzed
by FACS for their expression of the TCRa/(3, TCR V08, TCR
V06, and the IIT2R tx chain .
Results
BALB/c mice (three/group) were immunized with either
SEB emulsified inCFA or with CFA alone. Mice administered
SEB by this protocol displayed no discernible ill effects and
appeared healthy throughout the post-immunization period .
8 d after in vivo priming with SEB, lymph nodes or splenic
T cells were assayed for proliferation to SEB, SEA, PPD, and
F23.1 (antiV08) . SEA was used as a control because it is
a superantigen that activates V(31+, Vl3+, and Vo11+, but
not V08+ T cells (20) . Fig. 1 shows the in vitro prolifera-
tion oflymph nodeT cells from SEB- vs. CFAprimed BALB/c
mice after stimulation with SEB and SEA . The proliferation
of T cells from SEB-primed mice to SEB was dramatically
reduced in comparison with the SEB-induced proliferation
of T cells from mice primed with CFA alone (Fig . 1 A) .
In contrast, there was no significant difference between the
SEA- and PPD-induced proliferative responses ofT cells from
SEB/CFA vs . CFA-immunized mice (Fig. 1 B) . These results
were highly reproducible in several experiments . Because
V08+ T cells predominate in the response to SEB, it was
possible that the diminished SEB response occurred because
SEB administration had eliminated V08+ T cells (SEB also
activates V03+ T cells [20], but BALB/c mice express Mls°
and thus have eliminated all V03+ T cells by clonal dele-
tion [28, 29]) . Therefore, we examined the level ofV08 ex-
pression in the SEB- vs . CFA-primed mice. As shown in Fig.
2 A, the percentage ofT cells expressingV08 was comparable
in SEB- and CFA-primed animals . There appeared to be no
downregulation of the level of TCR on the V08+ cells in
SEB-primed animals. Moreover, the total number ofT cells
present in the lymph nodes and spleens of SEB/CFA- and
CFA-primed mice were also comparable (Fig. 2) . In four sep-
arate experiments, the mean percentages of tx/a+ T cells ex-
pressing V08 8 d after immunization were 27.5 ± 1.47%
for SEB/CFAprimed animals and 28.0 ± 2.2% for CFA-
primed animals. Significantly, both CD4+ and CD8+ T
cells were well represented among the V08+ T cells from
the SEB-primed mice (Fig. 2 B) .
We next examined the proliferative capacity of V08+ T
cells in each group by directly activating T cells with the
V08-specific mAb, F23 .1 (Fig . 3) . The data in Fig . 3A show
a >90% reduction in the F23.1-induced proliferation in the
SEB-primed mice compared with the CFA-primed controls .
Because the degree of inhibition ofV#8+ T cells was -90%Figure 1 .
￿
Lymph node T cells from BALB/c mice immunized subcutane-
ously with SEB are profoundly unresponsive to subsequent in vitro re-
stimulation with SEB, but respond normally to SEA . Pooled nylon
wool-purified T cells from three mice per group immunized with either
SEB emulsified in CFA or CFA alone were stimulated in vitro (105 T
cells/well) with 5 x 105 irradiated (2,000 Cy) Thy-l-depleted syngeneic
spleen cells as a source ofAPC and various concentrations of SEB (A),
SEA (B), PPD at 20 Wg/ml, or medium alone. Counts per minute induced
by PPD were 21,502 for SEB-primedT cells and 19,645 for CFA-primed
T cells. The percent reductions in SEB-induced proliferation by the
SEB/CFA- compared with the CFA-primed T cells are shown for each
in vitro dose of SEB (A) . In three independent experiments identical to
the one shown here, the mean percent reductions in in vitro SEB-induced
proliferation of SEB/CFA vs . CFA-primed T cells were 10 hg/ml SEB,
81.2 t 1.4% ; 1 leg/ml SEB, 92 .1 ± 2.1% ; 0.1'íg/ml SEB, 92.4 ± 1.6% ;
0.01 Wg/ml SEB, 83 .8 ± 5 .3% . The error bars indicate theSEM of tripli-
cate determinations .
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Figure 2 .
￿
Flow cytometry analysis of cell surface phenotype of T lym-
phocytes from BALB/c mice immunized 8 d previously with either SEB
or CFA . (A) Analysis of total Vß8' cells nylon wool-purified lymph
nodes from mice (three/group) immunized with either SEB/CFA (top)
or CFA (bottom) . Percentages in the upper right hand corner of the Vß8
FRCS profiles represent percent of Vß8* cells as a fraction of total a/ß+
cells. The mean fluorescence intensity for Vß8' cells from SEB/CFA mice
was 389, and for Vß8' cells from CFA mice was 395 . The mean overall
T cell yields from these mice, calculated from four separate experiments
were (no . ofT cells per group; three mice in each group) : lymph nodes,
CFA-primed mice: 3.68 ± 1 .1 x 107; lymph nodes, SEB/CFA-primed
mice : 3.39 t 0.52 x 10 7; spleens, CFA-primed mice: 4.25 ± 0.08 x
107; spleens, SEB/CFA-primed mice: 4.95 ± 2.2 x 10 7 . (B) Two-color
flow cytometry analysis ofcell surface Vß8 vs. CD8 expression on T lym-
phocytes from BALB/c mice immunized 8 d before with either SEB/CFA
(right) or CFA (left) . The percent of cells that were TCR-a/ß " was 74%
for SEB/CFA mice, and 83% for CFA mice. The percent of Vß8' cells
that were CD8' was 50% for SEB/CFA mice and 38% for CFA mice,
while the percent of Vß8' T cells that were CD4+ was 50% for
SEB/CFA mice and 60% for CFA mice (not shown) .
and Vß8+ T cells were well distributed among the CD4+
and CD8+ subsets (Fig . 2 B), it can be inferred that SEB
has induced anergy in both subsets because both CD4+ and
CD8+ T cells can normally respond to TCR-specific anti-
bodies (30) . Moreover, the proliferation of VQ6+ T cells,Figure 3 .
￿
In vivo administration of SEB induces a state of unrespon-
siveness in Vß8+ T cells. Shown are the proliferative responses of nylon
wool-purified lymph node T cells from mice immunized subcutaneously
with either SEB/CVA or CFA to in vitro stimulation with plate-bound
antiVß8mAb (10 Wg/ml) or antiVß6mAb (10 lsg/ml) . (A) Proliferative
response of BALB/c T cells to antiVß8 antibodies; (p) CFA immune;
(*)SEB/CFAimmune. In three independent experiments, the mean per-
cent inhibition ofVß8-specific mAb-induced proliferation ofSEB-primed
T cells (105/well) was 85 .8 ± 3.7% . (B) Proliferative response of BALB/c
T cells to Vß8- andVß6-specific antibodies ; (/)SEB/CFAimmune with
antiVß8 ; (0) CFA immune with antiVß8;(A)SEB/CFAimmune with
antiVß6 ; (A) CFA immune with antiVß6 . (C) The proliferation of T
cells from BALB/c, B10, B10.BR, and B10.D2 to antiVß8 . The solid bars
represent proliferationofT cellsfromCFAimmunizedmice ; and the hatched
bars represent the proliferation ofT cells from SEB-immunized mice. The
percent reduction in proliferation of SEB-primed T cells is shown above
each bar. Proliferation is shown as V08-induced cpm minus medium
alone cpm .
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Table 1 .
￿
Priming with SEB Inhibits Prolfestive Response
of Splenic T Cells
Percent inhibition of SEB at :
Exp .
￿
10 Wg
￿
1.0 hg
￿
0.1 gg
￿
0.001 hg
1 84 96 99
￿
91
2 90 91 78
￿
91
Nylon wool-purified splenicT cells (10 5) from BALB/c mice immunized
subcutaneously with either SEB/CFA or CFA alone were stimulated with
5 x 105 irradiated (2,000 rad) Thy-1.2 - syngeneic spleen cells as a
source ofAPC in the presence ofvarying doses ofSEB or SEA, as described
in Materials and Methods . Shown is the percent reduction in SEB-induced
proliferation of SEB/CFA- vs . CFA-primed T cells. Responses were nor-
malized, based on the SEB response relative to the SEA response in
SEB/CFA- vs . CFA-primed animals to account for different percentages
of TCR-tx/ß+ cells in the spleen cell populations .
which are not reactive with SEB (20), to stimulation with
antiVß6 antibodies was comparable in the SEB- and CFA
immunized groups (Fig. 3B) . These data show that theun-
responsiveness induced by in vivo SEB administration was
specific and not due to a generalized T cell paralysis . The
Vß8-specific anergy was also not strain orMHCspecific, such
that similar inhibition of the Vß8 proliferative response was
observed in B10, B10.BR,B10D2, and C3H/HeJ mice primed
with SEB (Fig . 3 C and data not shown) .
To test whether inhibition was regionally confined to
draining lymph nodes, we also examined the proliferative re-
sponse of splenic T cells from SEB-immunized mice to in
vitro SEB stimulation . As shown in Table 1, there was also
adramatic decrease in the ability ofsplenicT cells from SEB-
immunized animals to proliferate after in vitro restimulation
with SEB- relative to CFA-primed controls. These data show
that the anergy induced by subcutaneous administration of
SEB is not solely a regional effect but exists in T cells re-
moved from the site of SEB administration .
Because one of the classical means of generating periph-
eralTcell tolerancehasbeen to inject proteins or cells intra-
venously, we next determined whetherSEB would also in-
duce tolerance after intravenous injection. SEBdiluted in PBS,
or PBS alone, was injected intravenously, and 8 d later, the
responses of splenicT cells to stimulation with SEB, SEA,
and antiVß8 antibodies were assayed for both groups . The
response ofT cells from intravenously SEB-immunized animals
to in vitro restimulation with both SEB and anti-Vß8 was
significantly reduced in comparison with the PBS controls
(Fig . 4,A and C) . In contrast, theresponses ofboth groups
to stimulation withSEAwere comparable (Fig. 4B) . As with
the subcutaneous administration of SEB, 8 d after intrave-
nous administration, there appeared to be no difference in
either the percentage ofVß8+ T cells or in the receptor den-
sity on Vß8+ cells between mice administered SEB/PBS vs.Figure 4 .
￿
SEB-administered intravenously induces anergy in Vß8 * T
cells . Nylon wool-purified BALB/c splenic T cells (105) from mice
(four/group) immunized intravenously with SEB in PBS (1,000,ug/mouse)
(hatched ban) or PBS alone (solid ban) were stimulated with 5 x 105 ir-
radiated Thy-1.2- syngeneic spleen cells as a source ofAPC in the pres-
ence of various doses of SEB (A) or SEA (B) . The percent reduction in
SEB-induced proliferation is shown above each bar for the SEB-immunized
T cells in A . Mice administered SEB intravenously appeared to be sluggish
for 2-3 d after injection but appeared entirely normal thereafter with no
discernible abnormalities. There were no deaths among mice given SEB
intravenously. Also, a virtually identical degree ofanergy was induced after
administration ofhalf the intravenous dose (500 F+g) of SEB given in this
experiment (data not shown) . (C) Varying numbers of the same T cells
were stimulated with plate-bound anti-Vß8 mAb. The open squares rep-
resent the proliferation of T cells from mice given PBS intravenously, and
the closed diamonds represent the proliferation ofT cells from mice given
SEB intravenously.
PBS alone (data not shown) . Also, there was no significant
difference between the two groups in the number of splenic
T cells recovered (data not shown) . Therefore, these data in-
dicate that the intravenous administration ofSEB also results
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in the specific induction of anergy in Vß8+ peripheral T
cells .
We next examined the duration of the SEB-induced toler-
ance. Profound inhibition persisted for at least 4 wk after
in vivo SEB administration (Fig . 5) . Interestingly, however,
2 wk after SEB administration, and thereafter, there was a
highly reproducible 50-60% decrease in the number of
Vß8 + T cells in SEB- as compared with CFA-primed mice
(Fig. 5) . The remaining Vß8+ T cells expressed normal
receptor levels (data not shown) . Because the SEB- and anti-
Vß8-induced proliferation ofT cells from SEB-primed animals
was reduced by 80-90%, the decrease in absolute numbers
of Vß8+ cells can not fully account for the absence of the
Vß8+ T cell response seen in SEB-primed mice . Thus, these
data suggest that a proportion of the Vß8+ T cells from
SEB-primed mice that are anergic 8 d after priming are deleted
by day 14 post-priming, and that the remaining Vß8+ cells
persist in an unresponsive state.
To begin to examine the mechanism of SEB-induced un-
responsiveness, we studied IL2R expression and the IIr2 re-
sponsiveness ofSEB-tolerized T cells. In the experiment shown
(Fig. 6), 2 d after in vitro restimulation with SEB, Vß8+
T cells from SEB-primed mice were able to express IL2R,
although this expression was reduced somewhat (50% vs.
76%) when compared with CFA controls . Also, after 2 d
of in vitro stimulation with SEB, 42% of the T cells from
CFA-primed animals were Vß8+, as compared with only
24% for SEB-primed animals, consistent with the failure of
the Vß8+ T cells from these latter mice to proliferate in re-
sponse to SEB in vitro . The addition of exogenous IL2 at
the initiation ofculture had little effect on the ability ofVß8
cells to proliferate in response to restimulation with SEB (Fig.
6) . This suggests that the anergized T cells are defective in
both their ability to express normal levels of IL2R, and to
proliferate in response to IL-2 .
In the course of our studies, it was found that, although
all strains assayed showed Vß8-specific SEB-induced anergy,
onlyBALB/c and C3H/HeJ mice responded with a consis-
tent decrease to in vitro restimulation with SEB (data not
shown) . T cells from B10, B10.D2, and B10.BR mice re-
sponded inconsistently to in vitro restimulation with SEB.
BALB/c and C3H/HeJ mice are Mls° and therefore delete
Vß3+ T cells (28, 29), whereas B10, B10.132, and B10.13R,
mice are Mlsb and have peripheral V03' cells. Since SEB is
known to activate Vß3+ as well as Vß8+ T cells in vitro
(20), it was possible that in vivo SEB administration was not
affecting Vß3+ and Vß8+ T cells equally. To address this
issue, lymph node T cells from SEB-immunized B10 mice
(Mlsb) were assayed for proliferation to both antiVß8 and
antiVß3 plate-bound antibodies . As shown in Fig. 7, there
was a significant reduction in the proliferation ofT cells from
SEB-immunized animals to antiVß8 stimulation in compar-
ison with control T cells, while their response to antiVß3
stimulation was identical to that of the controls . These data
indicate that in vivo administration of SEB induces anergy
in a VO-specific manner, such that not all Vß-expressing T
cells capable of being activated by SEB in vitro are tolerized
after in vivo SEB administration .VS8* lymph node T cells at 14 and 30 d after SEB/CFA vs.
30 d, CFA, 34.2 ± 4.0% ; 30 d, SEB/CFA, 16.0 ± 2.8%.
Discussion
The advent of transgenic mice and specific antiTCR re-
agents has made possible the direct demonstration of in-
trathymic clonal deletion (1-5), and the intrathymic induc-
tion of clonal anergy during development (6) . Tolerance of
mature peripheral T cells toMHC antigens (12) and Mls an-
tigens (13) has been demonstrated under conditions where
T cells expressing TCRs known to be reactive for these an-
tigens were not deleted (were present in normal numbers) .
These results suggested that the peripheral tolerance was due
to clonal anergy, although direct stimulation with TCR-
specific antibodies was not investigated . In this report, we
have shown directly the in vivo induction, by a Va-specific
mitogen, of T cell tolerance due to clonal anergy . We have
found that after the in vivo administration of SEB (either
subcutaneously emulsified inCFA, or intravenously in PBS),
V08+ T cells become unresponsive to subsequent restimu-
lation with either SEB or antiV08 antibodies (F23.1) . Though
previous studies have reported nonspecific immune suppres-
sion after in vivo administration of SE (31-33), the unrespon-
siveness we describe in this report is specific since the same
cell population will respond normally to restimulation with
SEA, PPD, or V03- and V(06-specific antibodies. Other mech-
anisms to account for this tolerance were ruled out . First,
the SEB-induced unresponsiveness does not appear to be due
to residual SEB blocking ofVa8+ TCRs because F23 .1 was
able to stain Va8+ cells from SEB-primed mice with the
same intensity as Va8+ cells from CFA-primed mice, sug-
gesting that SEB is not blocking the binding of F23.1 to
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Figure 5 .
￿
SEB-induced anergy is
long lived . Nylon wool-purified T
cells from BALB/c mice immunized
14 or 30 d earlier with SEB or CFA
were assayed for proliferation to SEB
(A), SEA (B), or PPD, as in Fig.
1 . Proliferation to anti-V08 (C) was
assayed as in Fig . 2 . Cross-hatched
and dotted bars represent antiV08-
induced proliferation ofT cells from
SEB-primed mice, solid andhatched
bars represent the antiVS8-'induced
proliferation of T cells from CFA-
primed mice . PPD controls were :
21,083 cpm, SEB, 14 d ; 11,542 cpm,
SEB 30 d; 17,083 cpm, CFA, 14 d ;
and 14,482 cpm, CFA, 30 d . In
three experiments, the mean percent
decrease in SEB (1 hg/ ml)-induced
proliferation of SEB-primed T cells
compared with controls was 84 .8
4.4% at 2 wk after immunization
and 79.5 ± 14% after 1 mo. (D)
Summary of percent VS8* T cells,
percent inhibition of the SEB re-
sponse, and percent inhibition ofthe
response toV08-specific antibodies,
1, 2, and 4wk after SEB immuni-
zation. The mean percent (± SD)
CFA immunization were : 14 d, CFA, 30.4
￿
0.58% ; 14 d, SEB/CFA, 13 .3 ± 2.6% ;
These values were determined from two separate experiments, with six mice/group.
V08+ TCRs . In addition, mixing experiments with cells
from CFA- and SEB-primed animals eliminated the possi-
bility that suppressor cells were responsible for the tolerance
(data not shown) .
The fact that SEB belongs to the group of superantigens
that stimulate T cells on the basis of V(d expression alone
suggests a possible mechanism to explain tolerance induc-
tion in this system . Recent studies have shown a rise in intra-
cellular Cal+ levels and modulation of the TCR complex
after T cell clones were incubated with SEB in the absence
of APC (34) . This suggests that SEB can directly bind and
induce signaling through the TCR . Because an increase in
intracellular Caz+ levels in the absence of other accessory
signals has been suggested as one mechanism for tolerance
induction in vitro (10, 35, 36) ; it is possible that SEB in-
duces anergy in VQ8+ cells because it is able to directly bind
and induce signaling through the TCR in the absence of ac-
cessory signals provided byAPC . The failure ofSEB to tolerize
V03+ T cells in vivo while it does tolerize V08+ T cells
may reflect differences in the relative affinity that SEB has
for V(33 vs . V08 TCRs .
SEs have also been shown to bind directly to class 11 mole-
cules with high affinity (37, 38), and the in vitro stimulatory
effect of SEs is believed to be based on their ability to cross-
link the TCRs on T cells with class II molecules on APC
(34, 39) in the absence of antigen processing . Thus, toler-
ance induction by SEB could also result from a very high
affinity interaction between the SE/la complex and the TCR,Figure 6 .
￿
Exogenous IL2 does not overcome SEB-induced anergy. (A)
The IL2R expression of Vß8* T cells from SEB/CFA- and CFA-primed
mice. Nylon wool-purified lymph nodeT cells from SEB/CFA- or CFA-
primed mice were cultured in 10 hg/ml SEB with Thy-1 .2 - APC for 48 h
before staining for IL2R expression . The overall percentage of Vß8* T
cells and the percentage of V08* T cells expressing IL2R were deter-
mined by two-color flow microfluorometry . (B) The in vitro proliferative
response of T cells from SEB/CFA- and CFA-primed mice to SEB with
and without the addition ofexogenous 11,2 . (E) SEB/CFA primed, without
IL2 ; (/) SEB/CFA primed, with 11,2 ; (®) CFA primed, without IL-2 ;
(11) CFA primed, with IL-2 . Nylon wool-purified lymph node T cells
from SEB/CFA- or CFA-immunized mice (four/group) were stimulated
as in Fig . 1 with or without the addition of IL-2 (102 U/ml) . 11,2 was
added at the initiation of the culture period .
perhaps involving predominant presentation by B lympho-
cytes, which are relatively poor at providing accessory signals
(40-42) . In this context, it was recentlyshown that the rela-
tive potency of peptide antigens in vitro correlated directly
with their capacity to induce tolerance in vivo (43) . Moreover,
in the murine experimental allergic encephalomyelitis model,
analogues of the encephalitogenic MBP-1-9 peptide that were
more potent than the native peptide at activating encephalito-
genicT cell clones in vitro paradoxically were protective against
diseasewhen administered in vivo (44) . It was suggested that
the in vivo administration of such peptides could result in
the tolerization of the encephalitogenicT cell clones by clonal
anergy (44) . SEs have also been shown to activate T cells in
vivo, and it has been demonstrated that T cell activation and
lymphokine release may be responsible for some of the
manifestations of systemic staphylococcal infection (33) . It
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In vitro administration ofSEB does not inhibit the response
of Vß3' T cells . Nylon wool-purified lymph node T cells from B10 mice
immunized subcutaneously with either SEB/CFA or CFA alone (three/group)
were stimulated as in Fig. 2 with antiVß8 : ([I) SEB/CFA primed; (N)
CFA primed; and antiVß3 mAbs (" ) SEB/CFA primed ; (O) CFA primed .
would be of interest to define the parameters of toxin ad-
ministration that lead alternatively to T cell activation or the
induction of tolerance .
2 wk after SEB administration, Vß8+ T cells were dimin-
ished in number, although the remainder were still anergic.
The intensity ofVß8 expression on these cells appears to be
normal, indicating that the decrease in Vß8 cells is not due
to receptor downregulation . It is also doubtful that the di-
minished number of Vß8+ T cells after 2 wk is due to SEB-
induced intrathymic deletion because the decrease consistently
occurs between day 8 and 14 post-immunization, and it is
unlikely that 40-50% of all peripheral Vß8+ cells are nor-
mally replaced during a 6-d period . In addition, preliminary
experiments indicate that there is minimal downregulation
ofVß8 on cortisone-resistant thymocytes 8 d after subcuta-
neousSEB administration (unpublished data) . Therefore, these
data suggest that in vivo administration of SEB may result
in the clonal deletion of some peripheral Vß8+ T cells .
The fact that some Vß8+ cells first appear to be anergized
and then proceed to clonal deletion suggests that the clonal
anergy observed and the subsequent deletion of a portion of
the anergized cellsmay be discrete stages ofa continuing pro-
cess . Recent studies demonstrate some similarities between
the intracellular mechanisms leading to anergy and to clonal
deletion, such as dependence on an earlyTCR-CD3-mediated
Cal+ flux, and sensitivity to cyclosporine A (45-50) . How-
ever, clonal deletion is not an inevitable consequence ofanergy
induction because at least 50% of the Vß8+ cells were able
to persist in a state of anergy. In addition, in other reported
examples ofT cell tolerance due to anergy, the anergized cells
were not clonally deleted and persisted for extended periods
of time (6, 13) . The decision to progress from anergy to de-
letion could depend on factors such as the maturation stateof the T cell, or the intensity and duration of the stimulus
a cell receives through its TCR (51) .
In vitro models ofT cell anergy suggest that a major de-
fect in these cells is their inability to produce IL2 . In the
case of in vitro anergized cells, the anergized T cell clones
were still fully responsive to exogenously added 11,2 (50) .
However, our model of in vivo induced anergy, as well as
that of others (6, 13), suggest the defect is more generalized
than this . Upon in vitro restimulation with SEB, -40-50%
of the V08' T cells from SEB-primed mice express normal
levels of IL2Rs. The remainder either do not express IL2Rs
at all or do so at undetectable levels . Even so, all these cells
are only minimally responsive to exogenous IL-2 . The fact
that 50% of the V08+ cells can be IL2R+ but are neverthe-
less unresponsive to exogenous IL2 suggests that stages of
activation in addition to the production of IL2 are blocked
in peripherally anergized T cells. These additional defectsmay
be at the level ofIL2R expression (i .e ., an ability to express
high affinity IL-2 receptors), or an inability to transmit the
signal normally delivered by 11,2 . Although other models
of in vivo T cell anergy also find that anergized cells are only
minimally responsive to exogenous IL2 (6, 13), in the case
of Rammensee et al . (13), the anergic V06+ cells rendered
tolerant after the in vivo administration of Mls, spleen cells
expressed normal levels of IL2Rs after activation .
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Although soluble protein antigens have long been used to
study the induction of tolerance in both T and B cells, they
were ineffective as tolerogens if administered subcutaneously,
particularly if emulsified in adjuvant . Most proteins studied
as tolerogens were administered intravenously or orally, in
an unaggregated form, or at very high doses or very low doses
(15-19) . SEB thus differs from conventional protein antigens
in that it induces anergy when administered subcutaneously
in CFA as well as intravenously. This may reflect the fact
that the trimolecular interaction between SE, the la mole-
cule, and the TCR is very likely to be distinct from that of
conventional protein antigens (52, 53) . Superantigens may
bind directly to Ia molecules outside the putative antigen
binding groove, and in view of their activation of T cells
based on TCR V/3 expression alone, they probably interact
with a region ofthe V(3 protein not involving the third com-
plementarity determining region formed by VDJ recombi-
nation (52, 53) . If this is true, it raises the possibility that
if the mechanism by which SEs bind to specific V(3 TCRs
can be understood, it may be possible to design peptides that
mimic this binding and that can be used to suppress or am-
plifyimmune responses in a T cell Va-specific manner. Such
peptides could be useful to specifically control autoimmune
diseases that are mediated by a limited set of V(3+ T cells
(54-56) .
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